FDA approval for MNKD's AFREZZA
Byergo: LLY has been no ball of fire over the last six months but neither has MNKD. If MNKD's diabetes drug is superior to LLY's(the drugs' of both companies still in the test stage) why have both stocks underpreformed in the stock market?